- Home
- TAK vs KR Comparison
TAK vs KR Comparison
Compare TAK & KR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- KR
- Stock Information
- Founded
- TAK 1781
- KR 1883
- Country
- TAK Japan
- KR United States
- Employees
- TAK N/A
- KR N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- KR Food Chains
- Sector
- TAK Health Care
- KR Consumer Staples
- Exchange
- TAK Nasdaq
- KR Nasdaq
- Market Cap
- TAK 42.2B
- KR 43.5B
- IPO Year
- TAK N/A
- KR N/A
- Fundamental
- Price
- TAK $14.87
- KR $67.69
- Analyst Decision
- TAK
- KR Buy
- Analyst Count
- TAK 0
- KR 16
- Target Price
- TAK N/A
- KR $66.94
- AVG Volume (30 Days)
- TAK 1.5M
- KR 6.8M
- Earning Date
- TAK 05-08-2025
- KR 03-06-2025
- Dividend Yield
- TAK 3.96%
- KR 1.89%
- EPS Growth
- TAK 15.39
- KR 23.99
- EPS
- TAK 0.83
- KR 3.67
- Revenue
- TAK $29,124,927,177.00
- KR $147,123,000,000.00
- Revenue This Year
- TAK $8.53
- KR $4.29
- Revenue Next Year
- TAK N/A
- KR $2.43
- P/E Ratio
- TAK $34.06
- KR $18.44
- Revenue Growth
- TAK 9.83
- KR N/A
- 52 Week Low
- TAK $12.58
- KR $49.04
- 52 Week High
- TAK $15.31
- KR $68.51
- Technical
- Relative Strength Index (RSI)
- TAK 53.68
- KR 61.06
- Support Level
- TAK $14.90
- KR $65.72
- Resistance Level
- TAK $15.17
- KR $65.66
- Average True Range (ATR)
- TAK 0.17
- KR 1.33
- MACD
- TAK -0.07
- KR 0.09
- Stochastic Oscillator
- TAK 21.43
- KR 86.67
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About KR Kroger Company (The)
Kroger is one of the largest grocery retailers in the United States with more than 2,700 stores across a portfolio of over 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The firm also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.